Trial intelligence / Profile preview

Sertraline for Premenstrual Syndrome and PMDD

NCT00048854Phase 2Completed

Sponsor
Yale University
Start
Sep 2001
Primary completion
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sertraline in premenstrual syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), sponsored by Yale University. Started Sep 2001; status: completed.

02

Drugs

sertraline
03

Conditions

premenstrual syndrome (PMS)Premenstrual Dysphoric Disorder (PMDD)

Beyond the preview

Go deeper on NCT00048854.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00048854.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call